Efficacy and safety of the therapy of a disease involving a primary melanoma on a long-term basis (Health Services Research MELANOMA)
- Conditions
- C43Malignant melanoma of skin
- Registration Number
- DRKS00003715
- Lead Sponsor
- ADO Tübingen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 1353
Inclusion Criteria
Patient who has been diagnosed with new onset skin cancer (= primary melanoma) in the in the period from 01.04.08-31.06.08
Exclusion Criteria
no further information
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the long-term outcomes of primary melanoma patients in DRKS00003715 observational study?
How does DRKS00003715 compare to standard-of-care therapies for C43 malignant melanoma of skin?
What biomarkers correlate with improved survival in DRKS00003715 melanoma health services research?
What adverse events are associated with DRKS00003715 observational study on primary melanoma therapy?
How do DRKS00003715 findings influence combination therapy strategies for C43 malignant melanoma?